Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Rat (Rattus) Antibodies:
anti-Mouse (Murine) Antibodies:
Go to our pre-filtered search.
Human Polyclonal GLIPR1 Primary Antibody for ELISA - ABIN449364
Ren, Li, Yang, Timme, Goltsov, Ren, Ji, Addai, Luo, Ittmann, Thompson: RTVP-1, a tumor suppressor inactivated by methylation in prostate cancer. in Cancer research 2004
High GLIPR1 expression is associated with cisplatin resistance in lung cancer.
The present study identified GLIPR1 and miR-16 (show GDE1 Antibodies) as key components for regulating the proliferation, migration, invasion and cancer-initiating cells in osteosarcoma
This study reveals a novel pathway that PRMT5 (show PRMT5 Antibodies)/WDR77 (show WDR77 Antibodies) regulates GLIPR1 expression to control lung cancer cell growth.
Overexpression of RTVP-1 in human neural stem cells induced mesenchymal differentiation, whereas silencing of RTVP-1 in glioma stem cells (GSCs) decreased the mesenchymal transformation and stemness of these cells.
RTVP-1 regulates glioma cell spreading, migration and invasion and that these effects are mediated via interaction with N-WASP (show WASL Antibodies) and by interfering with the inhibitory effect of hnRNPK (show HNRNPK Antibodies) on the function of this protein.
Data indicate that combining adenoviral vector-mediated GLIPR1 gene therap (AdGLIPR1) with radiotherapy may achieve additive or synergistic tumor control in selected prostate and bladder tumors.
Based on the observed overexpression in AML (show RUNX1 Antibodies) samples, GliPR1 should be further explored as a potential target for AML (show RUNX1 Antibodies)
miR (show MLXIP Antibodies)-137 inhibits Glioblastom stem cell self-renewal and promotes their differentiation by targeting RTVP-1 which down-regulates CXCR4 (show CXCR4 Antibodies).
GLIPR1 interacts with Hsc70 (show HSPA8 Antibodies), and GLIPR1 overexpression or Hsc70 (show HSPA8 Antibodies) knockdown leads to transcriptional suppression of AURKA (show AURKA Antibodies) and TPX2 (show TPX2 Antibodies).
GLIPR1 core structure has a conserved central cavity via which CAP proteins are likely to bind to shared ligands.
The genetic variation is a key determining factor for the alternative splicing events in the Gli1 (show GLI1 Antibodies) 5' UTRs, which have functional implications on translational efficiency.
Identification of a novel mouse gene, mRTVP-1, as a p53 (show TP53 Antibodies) target gene. The mRTVP-1 protein has 255 amino acids and differs from the human RTVP-1 protein by two short in-frame deletions of two and nine amino acids. (mRTVP-1)
This gene encodes a protein with similarity to both the pathogenesis-related protein (PR) superfamily and the cysteine-rich secretory protein (CRISP) family. Increased expression of this gene is associated with myelomocytic differentiation in macrophage and decreased expression of this gene through gene methylation is associated with prostate cancer. The protein has proapoptotic activities in prostate and bladder cancer cells. This gene is a member of a cluster on chromosome 12 containing two other similar genes. Alternatively spliced variants which encode different protein isoforms have been described\; however, not all variants have been fully characterized.
glioma pathogenesis-related protein 1-like
, GLI pathogenesis-related 1 (glioma)
, GLI pathogenesis-related 1
, glioma pathogenesis-related protein
, gliPR 1
, glioma pathogenesis-related protein 1
, protein RTVP-1
, related to testis-specific, vespid, and pathogenesis proteins 1
, testes-specific vespid and pathogenesis protein 1
, related to testes-specific, vespid, and pathogenesis proteins